596 Materials and Process Development for Hybrid Therapeutics
596 Materials and Process Development for Hybrid Therapeutics
Wednesday, November 16, 2016: 3:15 PM - 5:45 PM
Continental 5 (Hilton San Francisco Union Square)
Description:
This session is focused on the recent advances and challenges in the discovery, development and manufacturing of antibody drug conjugates (ADCs) and other hybrid therapeutics. The topics to be discussed include advances in protein optimization and expression, conjugation, purification and formulation strategies, advances and challenges in the development of robust and scalable processes, implementation of Process Analytical Technologies (PAT) for process monitoring, and utilization of single-use technologies in manufacturing.
Sponsor:
Pharmaceutical Discovery, Development and Manufacturing Forum
Co-Sponsor(s):
Pharmaceuticals (15B)
Chair:
Co-Chair:
See more of this Group/Topical: Pharmaceutical Discovery, Development and Manufacturing Forum